Quality Evaluation of Fufang Nanbanlangen Keli Based on HPLC Characteristic Fingerprint and Quantitative Analysis of Multi-components with Single Marker

LIU Zhu-jie; BI Fu-jun; LIN Tong

doi:10.12452/j.fxcsxb.24052987

您当前的位置：

首页 >

文章列表页 >

Quality Evaluation of Fufang Nanbanlangen Keli Based on HPLC Characteristic Fingerprint and Quantitative Analysis of Multi-components with Single Marker

Experimental Techniques and Methods | 更新时间：2024-11-26

- Quality Evaluation of Fufang Nanbanlangen Keli Based on HPLC Characteristic Fingerprint and Quantitative Analysis of Multi-components with Single Marker
- Journal of Instrumental Analysis Vol. 43, Issue 11, Pages: 1835-1842(2024)
- 作者机构：
  
  广州市药品检验所，国家药监局中成药质量评价重点实验室，广东广州 510160
- 作者简介：
- 基金信息：
- DOI：10.12452/j.fxcsxb.24052987
  CLC： O657.7;R284.1
- Published：15 November 2024，
  
  Received：29 May 2024，
  
  Revised：08 August 2024，
- 稿件说明：
移动端阅览
刘主洁,毕福钧,林彤.基于HPLC指纹图谱和一测多评法的复方南板蓝根颗粒质量评价[J].分析测试学报,2024,43(11):1835-1842.

LIU Zhu-jie,BI Fu-jun,LIN Tong.Quality Evaluation of Fufang Nanbanlangen Keli Based on HPLC Characteristic Fingerprint and Quantitative Analysis of Multi-components with Single Marker[J].Journal of Instrumental Analysis,2024,43(11):1835-1842.
刘主洁,毕福钧,林彤.基于HPLC指纹图谱和一测多评法的复方南板蓝根颗粒质量评价[J].分析测试学报,2024,43(11):1835-1842. DOI： 10.12452/j.fxcsxb.24052987.

LIU Zhu-jie,BI Fu-jun,LIN Tong.Quality Evaluation of Fufang Nanbanlangen Keli Based on HPLC Characteristic Fingerprint and Quantitative Analysis of Multi-components with Single Marker[J].Journal of Instrumental Analysis,2024,43(11):1835-1842. DOI： 10.12452/j.fxcsxb.24052987.

摘要

采用高效液相色谱法（HPLC）对复方南板蓝根颗粒进行指纹图谱研究和相似度评价，并结合主成分分析（PCA）、正交偏最小二乘判别分析（OPLS-DA）进行统计学研究。在此基础上，以秦皮乙素为内参物，计算单咖啡酰酒石酸和菊苣酸的相对校正因子，并利用外标法（ESM）验证一测多评法（QAMS）的可靠性。10批复方南板蓝根颗粒的指纹图谱中共确定13个共有峰，相似度为0.942~0.996。PCA、OPLS-DA模式识别结果均表明，不同厂家样品间的成分存在一定差异。QAMS与ESM检测数据表明，两种算法的差异不大。所建立的指纹图谱结合统计学分析和一测多评法评价模式经济可靠、准确可行，可用于完善复方南板蓝根颗粒的质量标准监控。

Abstract

The analysis was achieved by high-performance liquid chromatography（HPLC） and similarity of fingerprints evaluation. Additionally，principal component analysis（PCA） and orthogonal partial least squares discriminate analysis（OPLS-DA） were employed to explorate the overall data and differential compounds of Fufang Nanbanlangen Keli. At the same time，taking aesculetin as the internal standard，relative correction factors of caftaric acid and chicoric acid were calculated to establish the multi-components by single marker（QAMS） method. The correctness and practicability of this study was assessed by contrasting the data with external standard method（ESM）. 13 common chromatographic peaks were signed in fingerprints with 10 batches of Fufang Nanbanlangen Keli，and the similarities of each batch were 0.942-0.996. The PCA and OPLS-DA study showed that there were certain varies from different manufacturers. Compared with ESM data，the data of QAMS method were not significantly different. The established fingerprint combined with QAMS method are econimic and reliable，which can provide references and systematic studies for the comprehensive supervisory control of Fufang Nanbanlangen Keli.

关键词

复方南板蓝根颗粒指纹图谱一测多评秦皮乙素高效液相色谱

Keywords

Fufang Nanbanlangen Kelicharacteristic fingerprintQAMSaesculetinhigh-performance liquid chromatography

references

Pharmacopoeia Committee of the Ministry of Health of the People's Republic of China. Drug Standards for Ministry of Health of the People's Republic of China. Traditional Chinese medicine formulations. Volume 5（中华人民共和国卫生部药典委员会. 中华人民共和国卫生部药品标准中药成方制剂. 第五册），1992：108.

Li Q，Cheng T F，Xu Q T，Jia T Z. Chin. Pharm. J.李钦，程铁峰，许启太，贾天柱.中国药学杂志），2004，（12）：58-60.

Wen Y. Drug Stand. Chin. （温琰. 中国药品标准），2006，（3）：64-65.

Wang J P，Sun C P，Lin H X，Wang Y，Wang S L. Chin. J. Exp. Tradit. Med. Formulae（王金鹏，孙翠萍，林海霞，王砚，王书林. 中国实验方剂学杂志），2012，18（21）：128-130.

Zhang L S，Sun W W，Xu Z H，Guo H Z. Chin. J. Pharm. Anal. （张利沙，孙玮玮，徐自慧，郭怀忠.药物分析杂志），2017，37 （10）：1845-1850.

Wu X F，Zhou X，Huang X L，Wu H Q，Xie B. J. Instrum. Anal.（吴学峰，周熙，黄晓兰，吴惠勤，谢斌. 分析测试学报），2022，41（3）：299-308.

Li Q，Du S M，Zhang Z L，Lü C M，Zhou Y Q，Zhao Y，Zhang N. Chin. Tradit. Herb. Drugs（李强，杜思邈，张忠亮，吕春明，周永全，赵燕，张宁.中草药），2013，44 （22）：3095-3104.

Wang Z M，Qian Z Z，Zhang Q W，Zhu J J，Gao H M，Wang Z T. Chin. J. Chin. Mater. Med.（王智民，钱忠直，张启伟，朱晶晶，高慧敏，王峥涛.中国中药杂志），2011，36（6）：657-658.

Xu Z Q，Zhao Z M，Ma Q，Yang D P，Xu X J. Mod. Tradit. Chin. Med. Mater. Med.-World Sci. Technol.（徐志琴，赵志敏，马庆，杨得坡，徐新军. 世界科学技术-中医药现代化），2021，23（9）：3365-3375.

Liu Y F，Liu Z W，Ren Y R，Liu Y. Chin. Archives Tradit. Chin. Med.（刘亦菲，刘兆薇，任一冉，刘颖.中华中医药学刊），2024，42（8）：132-141.

Li Y Y，Mao Y，Liang Z E N，Yang C L，Wu J，Yuan Z H，Yuan L Y. Chin. Ani. Hus. Vet. Med.（李媛媛，毛妍，梁曾恩妮，杨成林，邬静，袁志航，袁莉芸. 中国畜牧兽医），2023，50（7）：2998-3006.

Chu Z D，Cai B. Tradit. Chin. Drug Res. Clin. Pharmacol.（储正达，蔡彬.中药新药与临床药理），2024，35（2）：291-298.

Yang N，Tian G，Zhu M M，Li C，Bu W Q，Chen J，Hou X F，Liu Y，Wang G，Jia X B，Di L Q，Dong Z B，Feng L. J. Ethnopharmacol.，2016，194：395-402.

Saima，Irfan A，Saima N，Kashif B，Hiba-Allah N，Yousef A，Bin J，Mohammed B. ACS Omega，2023，8（31）：28196-28206.

Zhang W J，Wang X Y，Li X Y，Li H Y. Chin. J. Pharm. Anal.（张文静，王晓燕，李向阳，李海燕. 药物分析杂志），2020，40（2）：329-336.

Shi Y F，Shao Y，Wang X Y. J. Shanghai Univ. Tradit. Chin. Med. （施燕峰，邵艳，王晓燕. 上海中医药大学学报），2022，36（4）：59-64.

Cheng Y C，Wang Y E，He S L，Wang X Y，Ni Y. Chin. New Drugs J.（程玉钏，王玉娥，贺石麟，王小芸，倪艳. 中国新药杂志），2022，31（12）：1223-1229.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Separation of Chiral Compounds Using a Chiral Metal-Organic Framework ［Cu3(HL)2(L)2(bpy)3］·4H2O for High Performance Liquid Chromatography

Related Author

SHENG Wan-li

HAN Yi-zhi

ZHENG Shu-zhan

LUO Sun-lin

GUO Qi

ZHAO Dan

GONG Quan-quan

WANG Xiong

Related Institution

Hohhot Customs Technology Center

State Key Laboratory of Animal Nutrition

Clover Technology Group Inc.

云南师范大学化学化工学院

Address：100 Xianlie Middle Road, Guangzhou Postal code：510070
Tel：020-87684776,37656606 Fax：020-87684776 Email：fxcsxb@china.com
Technical support is provided by Beijing Founder electronics co., LTD 粤ICP备12017312号-3 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰